Measurement unit, method of manufacturing measurement unit, and biological sample measurement method

The measurement unit with a frozen reagent mixture and rotor simplifies biological sample measurement by maintaining solution quality and reducing on-site preparation complexity.

JP2024159476APending Publication Date: 2024-11-08HAMAMATSU PHOTONICS KK
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
JP2024009568
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-04-28
Filing Date
2024-01-25
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

Existing biological sample measurement techniques face challenges with reagent deterioration at room temperature and require complex operations near the subject, complicating the preparation and introduction of solutions into containers.

Method used

A measurement unit with a first storage space containing a frozen mixture of reagents and a rotor for stirring, allowing transport near the subject and simplifying operations by thawing and mixing near the subject.

Benefits of technology

Maintains solution quality and simplifies operations by enabling frozen storage and transport, followed by thawing and mixing near the subject, thereby improving measurement efficiency.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024159476000001_ABST
    Figure 2024159476000001_ABST
Patent Text Reader

Abstract

To provide a measurement unit that enables maintenance of the quality of a solution and simple work, a method of manufacturing the measurement unit, and a biological sample measurement method.SOLUTION: A measurement unit is used to measure characteristics of a biological sample. The measurement unit comprises a first container 4 and a first solution 6. The first container 4 includes a first storage space S1, an opening 4a communicating with the first storage space S1, and a light transmission region 4b transmitting light generated in the first storage space S1. The first solution 6 is a mixture of a plurality of reagents including an indicator reacting with a component produced from the biological sample. The first solution 6 is frozen while stored in the first storage space S1.SELECTED DRAWING: Figure 2
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a measuring unit, a method for manufacturing a measuring unit, and a biological sample measuring method. [Background technology]

[0002] Conventionally, there are known techniques for measuring the characteristics of biological samples (see, for example, Patent Document 1). In such techniques, a biological sample collected from a subject (e.g., a human body) is added to a prepared solution prepared by introducing a plurality of reagents into a container, and then the characteristics of the biological sample are measured by measuring light generated in the storage space of the container. [Prior art documents] [Patent documents]

[0003] [Patent Document 1] JP 2019-213464 A Summary of the Invention [Problem to be solved by the invention]

[0004] In the above-mentioned technique, at least one of the multiple reagents may be easily deteriorated at room temperature, and in such a case, it is desirable to perform operations such as preparation of the prepared solution and introduction of the prepared solution into the container immediately before measuring the light and in the vicinity of the test specimen. However, if these operations are performed in the vicinity of the test specimen, the operations may become complicated.

[0005] An object of the present invention is to provide a measurement unit that enables maintenance of solution quality and simple operation, a method for manufacturing a measurement unit, and a biological sample measurement method. [Means for solving the problem]

[0006] The measurement unit of the present invention is [1] "a measurement unit used for measuring characteristics of a biological sample, comprising: a first container including a first storage space, a first opening communicating with the first storage space, and a light-transmitting region that transmits light generated in the first storage space; and a first solution which is a mixture of multiple reagents including an indicator that reacts with a component generated from the biological sample, wherein the first solution is stored in the first storage space in a frozen state."

[0007] In this measurement unit, the first solution, which is a mixture of multiple reagents, is stored in a frozen state in the first storage space. This allows the measurement unit to be carried near the subject while the first solution is frozen, and after thawing the first solution near the subject, a biological sample collected from the subject can be added to the first solution. This not only maintains the quality of the first solution, but also eliminates the need for tasks such as preparing the first solution and introducing the first solution into the first container near the subject. Thus, this measurement unit maintains the quality of the first solution and simplifies the task of measuring the characteristics of the biological sample.

[0008] The measurement unit of the present invention may be [2] "the measurement unit according to the above [1], in which the biological sample contains white blood cells." The solution used to measure the characteristics of white blood cells may require frozen storage. As described above, since the first solution is frozen, frozen storage of the first solution is realized.

[0009] The measurement unit of the present invention may be [3] "the measurement unit according to the above [1] or [2], wherein the indicator is a fluorescent indicator." A solution containing a fluorescent indicator may require frozen storage. As described above, since the first solution containing a fluorescent indicator is frozen, frozen storage of the first solution containing a fluorescent indicator is realized.

[0010] The measurement unit of the present invention may be [4] "the measurement unit according to any one of the above [1] to [3], further comprising a rotor housed in the first housing space so as to be immersed in the first solution." In this way, the thawed first solution and the biological sample added to the first housing space can be stirred by the rotor, and dispersion of the biological sample in the first solution can be promoted.

[0011] The measurement unit of the present invention may be [5] "the measurement unit according to any one of the above [1] to [4], wherein the first container has a flat plate shape." This increases the specific surface area of ​​the first container compared to when the first container has a cylindrical shape, for example, and improves the thawing efficiency of the first solution.

[0012] The measurement unit of the present invention may be [6] "the measurement unit according to any one of the above [1] to [5], wherein the first container includes a curved inner surface." This allows the liquid contained in the first storage space to flow easily, facilitating dispersion of the biological sample in the first solution.

[0013] The measurement unit of the present invention may be [7] "the measurement unit according to any one of the above [1] to [6], further comprising a second container including a second storage space and a second opening communicating with the second storage space, and a second solution containing a stimulant that activates the function of the biological sample, the second solution being stored in the second storage space in a frozen state." This allows the measurement unit to be carried near the subject with the second solution frozen, and after thawing the second solution near the subject, the thawed second solution can be added to the first solution. Therefore, not only is the quality of the second solution maintained, but also an operation such as introducing the second solution into the second container is not required near the subject. Therefore, the quality of the second solution is maintained and the operation for measuring the characteristics of the biological sample is simplified.

[0014] The measurement unit of the present invention may be [8] "the measurement unit according to the above [7], in which a temporary storage space exists between the second solution and the second opening." In this way, even if a part of the thawed second solution moves toward the second opening, the part of the second solution is stored in the temporary storage space, so that leakage of the second solution from the second opening is suppressed.

[0015] The measurement unit of the present invention may be [9] "the measurement unit according to the above [8], in which the volume of the temporary storage space is equal to or larger than the volume of the second solution." This reliably prevents the second solution from leaking from the second opening.

[0016] The measurement unit of the present invention may be

[10] "the measurement unit according to any one of the above [7] to [9], wherein the second container is a pipette tip." This makes it easy to obtain the second container.

[0017] The manufacturing method of the measurement unit of the present invention is

[11] "A method for manufacturing a measurement unit used to measure characteristics of a biological sample, comprising: a first preparation step in which a first container is prepared, the first container including a first storage space, a first opening communicating with the first storage space, and a light-transmitting region that transmits light generated in the first storage space; and a first freezing step in which a first solution, which is a mixture of multiple reagents including an indicator that reacts with a component generated from the biological sample, is frozen while contained in the first storage space."

[0018] According to this method for manufacturing a measurement unit, it is possible to manufacture a measurement unit that exhibits the above-mentioned effects.

[0019] The manufacturing method of the measurement unit of the present invention may be

[12] "the manufacturing method of the measurement unit described in

[11] above, further comprising a solution preparation step in which the first solution is prepared, in which the plurality of reagents are mixed outside the first storage space." This allows the first solution prepared outside the first storage space to be introduced sequentially into the first storage spaces of the plurality of first containers, thereby improving the manufacturing efficiency of the measurement unit.

[0020] The method for manufacturing a measurement unit of the present invention may be

[13] "the method for manufacturing a measurement unit according to the above

[11] or

[12] , wherein in the first freezing step, the first solution is frozen in a state in which the rotor housed in the first housing space is immersed in the first solution." This makes it possible to manufacture a measurement unit having a rotor immersed in the first solution.

[0021] The method for manufacturing a measurement unit of the present invention may be

[14] "a method for manufacturing a measurement unit according to any one of

[11] to

[13] above, further comprising: a second preparation step in which a second container including a second storage space and a second opening communicating with the second storage space is prepared; and a second freezing step in which a second solution containing a stimulant that activates a function of the biological sample is frozen in a state in which it is contained in the second storage space." This makes it possible to manufacture a measurement unit that has the above-mentioned effects.

[0022] The method for manufacturing a measurement unit of the present invention may be

[15] "The method for manufacturing a measurement unit according to the above

[14] , wherein in the second freezing step, the second solution is frozen in a state in which a temporary storage space exists between the second solution and the second opening." In this way, even if a part of the second solution moves toward the second opening in the second freezing step, the part of the second solution is stored in the temporary storage space, and therefore leakage of the second solution from the second opening is suppressed.

[0023] The method for manufacturing a measurement unit of the present invention may be

[16] "the method for manufacturing a measurement unit according to the above

[15] , further comprising a solution introducing step of introducing the second solution into the second storage space before the second freezing step, in which the second solution is sucked into the second storage space through the second opening in the solution introducing step, and then air is further sucked into the second storage space through the second opening." This allows a temporary storage space to be formed between the second solution and the second opening.

[0024] The method for manufacturing a measurement unit of the present invention may be

[17] "the method for manufacturing a measurement unit according to the above

[16] , wherein the volume of the air sucked in the solution introducing step is equal to or greater than the volume of the second solution sucked in the solution introducing step." This reliably suppresses leakage of the second solution from the second opening.

[0025] The biological sample measurement method of the present invention is

[18] "a method for measuring characteristics of a biological sample, comprising: a preparation step in which a measurement unit described in any one of [7] to

[10] above is prepared; a first thawing step in which the first solution is thawed; a first adding step in which, after the first thawing step, the biological sample is added to the first storage space through the first opening; a second thawing step in which the second solution is thawed; a second adding step in which, after the second thawing step, the second solution is drawn out from the second opening and added to the first storage space through the first opening; and a measurement step in which light generated in the first storage space and transmitted through the light transmitting region of the first container is measured."

[0026] In this biological sample measurement method, a first solution, which is a mixture of a plurality of reagents, is prepared in a state in which it is contained in a first storage space of a first container and is frozen. As a result, the measurement unit can be carried near the subject with the first solution frozen, and after the first solution is thawed near the subject, a biological sample collected from the subject can be added to the first solution. Therefore, not only is the quality of the first solution maintained, but also, in the vicinity of the subject, work such as preparation of the first solution and introduction of the first solution into the first container is not required. Also, in this biological sample measurement method, a second solution is prepared in a state in which it is contained in a second storage space of a second container and is frozen. As a result, the measurement unit can be carried near the subject with the second solution frozen, and after the second solution is thawed near the subject, the thawed second solution can be added to the first solution. Therefore, not only is the quality of the second solution maintained, but also, in the vicinity of the subject, work such as introduction of the second solution into the second container is not required. As described above, according to this biological sample measurement method, the quality of the first and second solutions is maintained, and the work of measuring the characteristics of the biological sample is simplified.

[0027] The biological sample measurement method of the present invention may be the biological sample measurement method described in

[18] above, further comprising a temperature adjustment step of adjusting the temperature of the first solution after the first adding step, wherein in the first thawing step, the first solution is continuously heated so that the temperature of the first solution reaches an appropriate temperature for the biological sample, and in the temperature adjustment step, the first solution is heated so that the temperature of the first solution is maintained at an appropriate temperature for the biological sample. This allows the first solution to be thawed while maintaining an appropriate temperature environment for the biological sample.

[0028] The biological sample measurement method of the present invention may be

[20] "the biological sample measurement method described in

[19] above, wherein in the preparation step, a rotor immersed in the first solution is prepared, and in the temperature adjustment step, the first solution is heated while the rotor is rotated." This promotes temperature adjustment of the first solution and dispersion of the biological sample into the first solution. Effect of the Invention

[0029] According to the present invention, it is possible to provide a measurement unit that enables maintenance of solution quality and simple operation, a method for manufacturing a measurement unit, and a biological sample measurement method. [Brief description of the drawings]

[0030] [Figure 1] FIG. 2 is a front view of the measurement unit according to the embodiment. [Diagram 2] FIG. 2 is a front view of the first measuring kit shown in FIG. [Diagram 3] FIG. 3 is a cross-sectional view taken along line III-III in FIG. [Figure 4] FIG. 4 is a cross-sectional view taken along line IV-IV in FIG. [Diagram 5] 5 is a cross-sectional view taken along line VV in FIG. 4. [Figure 6] 2 is a partial cross-sectional view of the second measuring kit shown in FIG. 1. FIG. [Figure 7] 2A to 2C are diagrams showing steps of a method for manufacturing the measurement unit shown in FIG. 1. [Figure 8] FIG. [Figure 9] FIG. [Figure 10] FIG. 2 is a diagram showing steps of a biological sample measurement method using the measurement unit shown in FIG. [Figure 11] FIG. 13 is a diagram showing a modified example of the first measuring kit. [Figure 12] FIG. 12 is a cross-sectional view taken along line II-II in FIG. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0031] Hereinafter, an embodiment of the present invention will be described in detail with reference to the drawings. In each drawing, the same or corresponding parts are denoted by the same reference numerals, and duplicated explanations will be omitted.

[0032] The measurement unit 1 shown in FIG. 1 is used to measure a characteristic of a biological sample. The biological sample is, for example, blood (e.g., whole blood) of a subject (living organism). The subject is, for example, a human body. In this embodiment, the subject is a patient in a hospital. The biological sample includes, for example, white blood cells. The characteristic of the biological sample is, for example, the activity of white blood cells. In this embodiment, the characteristic of the biological sample is the activity of neutrophil cells.

[0033] Neutrophils are a type of white blood cell. The main role of neutrophils is to prevent infection by phagocytosing and killing bacteria and fungi that have invaded the body. Neutrophils take bacteria and other microorganisms into the neutrophil by wrapping them in the neutrophil plasma membrane. This results in the formation of a phagosome. When the phagosome fuses with a granule, the contents of the granule are released into the phagosome. The NADPH oxidase system formed in the cell membrane (phagosome membrane) generates active oxygen (superoxide, hydrogen peroxide), which kills bacteria and other microorganisms. In addition, the enzyme reaction of myeloperoxidase (EC number 1.11.2.2) contained in the granule contents produces hydrogen peroxide (H 2 O 2 ) and chloride ion (CI - ) produces hypochlorous acid (HOCl) (or its halogen equivalent), which kills bacteria and the like. Therefore, myeloperoxidase activity or superoxide production activity is used as an index for evaluating the activity of neutrophil cells. The measurement unit 1 of this embodiment is used to measure myeloperoxidase activity or superoxide production activity.

[0034] As shown in FIG. 1, the measurement unit 1 includes a first measurement kit 2 and a second measurement kit 3. As shown in FIG. 2 and FIG. 3, the first measurement kit 2 includes a first container 4, a rotor 5, and a first solution 6. The first container 4 includes a first storage space S1 and an opening (first opening) 4a. The opening 4a communicates with the first storage space S1. The first container 4 has, for example, a flat plate shape. The first container 4 has, for example, a rectangular plate shape.

[0035] The thickness T of the first container 4 (the length of the first container 4 in the Y-axis direction) is smaller than the width W1 of the first container 4 (the length of the first container 4 in the X-axis direction). The thickness T of the first container 4 is 1 / 3 or less of the width W1 of the first container 4. The thickness T of the first container 4 is smaller than the height W2 of the first container 4 (the length of the first container 4 in the Z-axis direction). The thickness T of the first container 4 is 1 / 3 or less of the height W2 of the first container 4. The height W2 of the first container 4 is larger than the width W1 of the first container 4. The height W2 of the first container 4 is 1.1 times or more the width W1 of the first container 4. The thickness T of the first container 4 is, for example, about 6 mm. The width W1 of the first container 4 is, for example, about 28 mm. The height W2 of the first container 4 is, for example, about 41 mm.

[0036] The first container 4 has a first member 41 and a second member 42. The first member 41 has, for example, a rectangular plate shape. The first member 41 includes main surfaces 41a, 41b and an accommodation space 41c. The main surfaces 41a and 41b face opposite each other in the Y-axis direction (thickness direction of the first container 4). The accommodation space 41c opens at one end of the first member 41 in the Z-axis direction (height direction of the first container 4). The accommodation space 41c reaches one end of the first member 41 in the Z-axis direction, but does not reach the other end of the first member 41 in the Z-axis direction. The accommodation space 41c has, for example, a rectangular shape when viewed from the Y-axis direction.

[0037] The first member 41 includes a recess 41d. The recess 41d is formed on the inner surface of the storage space 41c facing the opposite side to the main surface 41a. The recess 41d opens to one end of the first member 41 in the Z-axis direction. The depth of the recess 41d gradually increases from the other end of the first member 41 in the Z-axis direction toward the one end of the first member 41 in the Z-axis direction, and then remains constant. The width of the recess 41d in the X-axis direction is smaller than the maximum width of the storage space 41c in the X-axis direction. Both ends of the recess 41d in the X-axis direction are located inside both ends of the storage space 41c in the X-axis direction.

[0038] The second member 42 is disposed in the storage space 41c of the first member 41. As shown in Figs. 4 and 5, the second member 42 has, for example, a rectangular plate shape. The outer shape of the second member 42 approximately matches the shape of the storage space 41c. Specifically, the width of the second member 42 in the X-axis direction is the same as the width of the storage space 41c in the X-axis direction. The width of the second member 42 in the Y-axis direction is the same as the width of the storage space 41c in the Y-axis direction. The width of the second member 42 in the Z-axis direction is the same as the width of the storage space 41c in the Z-axis direction.

[0039] The second member 42 includes main surfaces 42a and 42b, a recess 421, a partition wall 422, and a support portion 423. The main surfaces 42a and 42b face opposite each other in the Y-axis direction. The main surface 42a faces the same side as the main surface 41a of the first member 41. The main surface 42a contacts the inner surface of the accommodation space 41c. The main surface 42b faces the same side as the main surface 41b of the first member 41. The main surface 42b contacts the inner surface of the accommodation space 41c. The recess 421 is formed in the main surface 42a. The recess 421 reaches one end of the second member 42 in the Z-axis direction, and does not reach the other end of the second member 42 in the Z-axis direction.

[0040] The partition wall 422 protrudes from the bottom surface of the recess 421. The height (width in the Y-axis direction) of the partition wall 422 is smaller than the depth of the recess 421. The top surface of the partition wall 422 is located between the main surface 42a and the main surface 42b. When viewed from the Y-axis direction, the partition wall 422 extends along the Z-axis direction. Both ends of the partition wall 422 in the Z-axis direction are located more inward than both ends of the recess 421 in the Z-axis direction. The partition wall 422 is a partial region of the second member 42.

[0041] The recess 421 includes a first region 42c, a second region 42d, and an intermediate region 42e. The first region 42c is located on one side of the partition wall 422 in the Z-axis direction. The first region 42c has, for example, a rectangular shape when viewed from the Y-axis direction. The first region 42c opens at one end of the second member 42 in the Z-axis direction. The second region 42d is located on the other side of the partition wall 422 in the Z-axis direction. When viewed from the Y-axis direction, the width of the second region 42d in the X-axis direction gradually decreases from one end of the second member 42 in the Z-axis direction to the other end of the second member 42 in the Z-axis direction. That is, the recess 421 includes an inner surface 42f having a curved surface shape. When viewed from the Y-axis direction, the inner surface 42f is curved toward the opposite side of the partition wall 422.

[0042] The intermediate region 42e is located between the first region 42c and the second region 42d. The intermediate region 42e is connected to both the first region 42c and the second region 42d. When viewed from the Y-axis direction, the intermediate region 42e has, for example, a rectangular shape. When viewed from the Y-axis direction, the position of one end of the intermediate region 42e in the Z-axis direction coincides with the position of one end of the partition wall 422 in the Z-axis direction, and the position of the other end of the intermediate region 42e in the Z-axis direction coincides with the position of the other end of the partition wall 422 in the Z-axis direction.

[0043] The support portion 423 is located in the second region 42d. The support portion 423 protrudes from the bottom surface of the recess 421. The surface of the support portion 423 is, for example, curved. The support portion 423 is a partial region of the second member 42.

[0044] The second member 42 includes an inclined region 42g (see also FIG. 3). The inclined region 42g is parallel to the X-axis direction and inclined with respect to the XZ plane. The inclined region 42g is formed in a region of the bottom surface of the recess 421 on one side in the Z-axis direction with respect to the partition wall 422. The inclined region 42g is inclined so as to approach the main surface 42b toward the opening 4a. One end of the inclined region 42g in the Z-axis direction reaches the main surface 42b. One end of the inclined region 42g in the Z-axis direction is located inside the opening 4a. The other end of the inclined region 42g in the Z-axis direction coincides with the position of one end of the partition wall 422 in the Z-axis direction. The width of the inclined region 42g in the X-axis direction is the same as the width of the recess 421 in the X-axis direction.

[0045] The first housing space S1 is a space of the housing space 41c excluding the second member 42. The opening 4a of the first container 4 is composed of an opening of the housing space 41c and an opening of the recess 421. The first container 4 includes a light-transmitting region 4b. The light-transmitting region 4b is a region of the first member 41 that overlaps with the first housing space S1 (recess 421) when viewed from the Y-axis direction. The light-transmitting region 4b is a portion of the first member 41 on the opposite side of the main surface 41b with respect to the first housing space S1. Light generated in the first housing space S1 passes through the light-transmitting region 4b. In this embodiment, the entire first member 41 and the second member 42 are light-transmitting. The material of each of the first member 41 and the second member 42 is, for example, a transparent resin or the like.

[0046] An identification surface 41e is formed on the main surface 41b of the first member 41. The identification surface 41e is parallel to the Z-axis direction and inclined with respect to the main surface 41b. The identification surface 41e extends to both ends of the first member 41 in the Z-axis direction. The identification surface 41e makes it easy to identify the main surface 41a including the light transmitting region 4b. The first member 41 is integrally formed from the same material. This prevents the first solution 6 contained in the containing space 41c from leaking out.

[0047] The rotor 5 is disposed in the second region 42d. The rotor 5 is, for example, rod-shaped. The rotor 5 is, for example, magnetic. The rotor 5 has a diameter of, for example, 1 mm or less, and a length of, for example, 10 mm or less. The rotor 5 has, for example, a core material and a plating layer formed on the surface of the core material. The core material is, for example, magnetic. The plating layer is made of, for example, gold. The rotor 5 rotates according to the rotation of a rotating device provided outside the first container 4. The rotor 5 rotates around an axis parallel to the Y-axis direction while being supported by the support portion 423.

[0048] The first solution 6 is accommodated in the first accommodation space S1. The first solution 6 fills a part of the first region 42c, the intermediate region 42e, and the second region 42d. The surface 6a of the first solution 6 is located between one end of the partition wall 422 in the Z-axis direction and the opening 4a. In other words, the first solution 6 does not reach the opening 4a. The rotor 5 is immersed in the first solution 6. In other words, the rotor 5 is accommodated in the first accommodation space S1 so as to be immersed in the first solution 6. The rotor 5 is buried in the first solution 6. Note that the first solution 6 is not shown in FIGS. 4 and 5.

[0049] The first solution 6 is a mixture of a plurality of reagents. The first solution 6 contains, as the plurality of reagents, for example, physiological saline, a buffer solution, a fluorescent indicator, and the like. The fluorescent indicator reacts with a component (HOCl) generated from the biological sample. The fluorescent indicator is, for example, aminophenyl fluorescein (APF), etc. As the fluorescent indicator, a commercially available product may be used.

[0050] The first solution 6 is frozen in a state where it is contained in the first containing space S1. The first solution 6 may be entirely frozen or partially frozen. The temperature of the first solution 6 is equal to or lower than the freezing point of any of the reagents contained in the first solution 6. That is, the temperature of the first solution 6 may be the same as the freezing point of any of the reagents contained in the first solution 6, or may be lower than the freezing point of any of the reagents contained in the first solution 6. In this embodiment, the temperature of the first solution 6 is equal to or lower than the freezing point of the reagent having the largest volume among the multiple reagents contained in the first solution 6. The temperature of the first solution 6 may be equal to or lower than the freezing point of the reagent having the lowest freezing point among the multiple reagents contained in the first solution 6. In this embodiment, the temperature of the first solution 6 is equal to or lower than the freezing point of the buffer solution contained in the first solution 6. The temperature of the first solution 6 may be equal to or lower than the freezing point of the fluorescent indicator contained in the first solution 6. In this embodiment, the temperature of the entire first measurement kit 2 is equal to or lower than the freezing point of any of the reagents contained in the first solution 6. The temperature of the first solution 6 is, for example, about -20°C. In this embodiment, the "temperature" refers to the temperature under atmospheric pressure.

[0051] As shown in FIG. 6, the second measurement kit 3 has a second container 7 and a second solution 8. The second container 7 has, for example, a cone shape with a line parallel to the Z-axis direction as a center line. The second container 7 has, for example, elasticity. The second container 7 includes a second storage space S2, an opening (second opening) 7a, and an opening (third opening) 7b (see FIG. 9). The openings 7a and 7b face in opposite directions to each other. The openings 7a and 7b are each connected to the second storage space S2. The second storage space S2 has, for example, a cone shape. The cross-sectional area of ​​the second storage space S2 decreases from the opening 7b toward the opening 7a. The diameter of the opening 7a is smaller than the diameter of the opening 7b. The opening 7a is an outlet of the second container 7. The opening 7a may function as an intake port of the second container 7. The second container 7 is, for example, a pipette tip or the like.

[0052] The second solution 8 is contained in the second storage space S2. The second solution 8 fills a part of the second storage space S2. A temporary storage space S3 exists between the second solution 8 and the opening 7a, and a space S4 exists between the second solution 8 and the opening 7b. Specifically, the second solution 8 is located inside each of the openings 7a and 7b. The second solution 8 includes a surface 8a facing the opening 7a and a surface 8b facing the opening 7b. The surface 8a is away from the opening 7a. The surface 8b is away from the opening 7b.

[0053] The volume of the temporary storage space S3 is equal to or larger than the volume of the second solution 8. The length of the temporary storage space S3 in the Z-axis direction (the distance between the opening 7a and the surface 8a) is equal to or larger than the length of the second solution 8 in the Z-axis direction (the distance between the surface 8a and the surface 8b). The volume of the space S4 is equal to or larger than the volume of the second solution 8. The length of the space S4 in the Z-axis direction (the distance between the opening 7b and the surface 8b) is equal to or larger than the length of the second solution 8 in the Z-axis direction. The volume of the space S4 may be smaller than the volume of the second solution 8. The length of the space S4 in the Z-axis direction may be smaller than the length of the second solution 8 in the Z-axis direction. The volume of the space S4 is equal to or larger than the volume of the temporary storage space S3. The length of the space S4 in the Z-axis direction is equal to or larger than the length of the temporary storage space S3 in the Z-axis direction. The volume of the space S4 may be smaller than the volume of the temporary storage space S3. The length of the space S4 in the Z-axis direction may be smaller than the length of the temporary storage space S3 in the Z-axis direction.

[0054] The second solution 8 is a mixture of a plurality of reagents. The second solution 8 contains, as the plurality of reagents, for example, a stimulant, an organic solvent, and a buffer solution. The stimulant is a reagent for activating the function of a biological sample. For example, the stimulant stimulates neutrophil cells of the biological sample in a pseudo manner. When the neutrophil cells are pseudo-stimulated, a natural immune response (biological defense response) of the neutrophil cells is induced. For example, the stimulant is fMLP (N-formyl-L-methionyl-L-leucyl-phenylalanine) or PMA (4β-phorbol-12-myristate-13-acetate). The organic solvent is a reagent for dissolving the stimulant in a powder state. For example, the organic solvent is DMSO (Dimethyl sulfoxide). The buffer solution is a reagent for diluting the organic solvent. Since the organic solvent is diluted by the buffer solution in the second solution 8, even if the second solution 8 is directly applied to the biological sample, the biological sample is prevented from being harmed by the organic solvent. As each of the stimulant, the organic solvent, and the buffer solution, for example, commercially available products may be used.

[0055] The second solution 8 is frozen in a state where it is contained in the second containing space S2. The second solution 8 is frozen in a state where a temporary containing space S3 exists between the second solution 8 and the opening 7a and a space S4 exists between the second solution 8 and the opening 7b. The second solution 8 may be entirely frozen or partially frozen. The temperature of the second solution 8 is equal to or lower than the freezing point of any of the reagents contained in the second solution 8. That is, the temperature of the second solution 8 may be the same as the freezing point of any of the reagents contained in the second solution 8, or may be lower than the freezing point of any of the reagents contained in the second solution 8. In this embodiment, the temperature of the second solution 8 is equal to or lower than the freezing point of any of the reagents contained in the second solution 8 that has the largest volume. The temperature of the second solution 8 may be equal to or lower than the freezing point of any of the reagents contained in the second solution 8 that has the lowest freezing point. In this embodiment, the temperature of the second solution 8 is equal to or lower than the freezing point of the buffer solution contained in the second solution 8. In this embodiment, the temperature of the entire second measurement kit 3 is equal to or lower than the freezing point of any of the reagents contained in the second solution 8. The temperature of the second solution 8 is lower than that of the first solution 6. The temperature of the second solution 8 is, for example, −40° C. or lower. In this embodiment, the temperature of the second solution 8 is −80° C. When the organic solvent is diluted with a buffer solution, the stimulant dissolved in the organic solvent may be easily deteriorated. In this embodiment, since the temperature of the second solution 8 is lower than that of the first solution 6 as described above (because it is an extremely low temperature), even if the organic solvent is diluted with a buffer solution in order to directly apply the second solution 8 to a biological sample, it is possible to store the second solution 8 while maintaining a state in which deterioration of the stimulant dissolved in the organic solvent is suppressed.

[0056] As described above, in the measurement unit 1, the first solution 6, which is a mixture of a plurality of reagents, is stored in a frozen state in the first storage space S1. This allows the measurement unit 1 to be carried near the subject while the first solution 6 is frozen, and after thawing the first solution 6 near the subject, a biological sample collected from the subject can be added to the first solution 6. Therefore, not only is the quality of the first solution 6 maintained, but also the work of preparing the first solution 6 and introducing the first solution 6 into the first container 4 is not required near the subject. Therefore, according to the measurement unit 1, the quality of the first solution 6 is maintained and the work of measuring the characteristics of the biological sample is simplified.

[0057] The biological sample contains white blood cells. A solution used to measure the characteristics of the white blood cells may require cryopreservation. As described above, the first solution 6 is frozen, and therefore cryopreservation of the first solution 6 is realized.

[0058] The indicator is a fluorescent indicator. A solution containing the fluorescent indicator may require frozen storage. As described above, the first solution 6 containing the fluorescent indicator is frozen, and therefore frozen storage of the first solution 6 containing the fluorescent indicator is realized.

[0059] The measurement unit 1 includes a rotor 5 accommodated in the first accommodation space S1 so as to be immersed in the first solution 6. This allows the thawed first solution 6 and the biological sample added to the first accommodation space S1 to be stirred by the rotor 5, and can promote dispersion of the biological sample into the first solution 6. In addition, the stirring by the rotor 5 can promote transfer of heat in the first solution 6, and can increase the efficiency of thawing the first solution 6 in the thawing step of the first solution 6.

[0060] The first container 4 has a flat plate shape. This increases the specific surface area of ​​the first container 4 compared to a case where the container has a cylindrical shape, for example, and therefore improves the thawing efficiency of the first solution 6.

[0061] The thickness T of the first container 4 is equal to or less than ⅓ of the width W1 of the first container 4. This improves the efficiency of heat transfer to the first storage space S1, and therefore improves the efficiency of thawing the first solution 6.

[0062] The height W2 of the first container 4 is 1.1 times or more the width W1 of the first container 4. This ensures the volume of the first storage space S1 and improves the thawing efficiency of the first solution 6.

[0063] The first container 4 includes an inner surface 42f having a curved shape, which allows the liquid contained in the first storage space S1 to flow easily, thereby facilitating dispersion of the biological sample in the first solution 6.

[0064] The measurement unit 1 includes a second container 7 and a second solution 8. The second container 7 includes a second storage space S2 and an opening 7a communicating with the second storage space S2. The second solution 8 includes a stimulant that activates the function of the biological sample. The second solution 8 is stored in a frozen state in the second storage space S2. This allows the measurement unit 1 to be carried near the subject with the second solution 8 frozen, and the second solution 8 can be thawed near the subject and then added to the first solution 6. Therefore, not only is the quality of the second solution 8 maintained, but also the work of preparing the second solution 8 and introducing the second solution 8 into the second container 7 is not required near the subject. Therefore, the quality of the second solution 8 is maintained and the work of measuring the characteristics of the biological sample is simplified.

[0065] A temporary storage space S3 exists between the second solution 8 and the opening 7a. As a result, even if a part of the thawed second solution 8 moves toward the opening 7a, the part of the second solution 8 is stored in the temporary storage space S3, so leakage of the second solution 8 from the opening 7a is suppressed. For example, when the position of the surface of the solution coincides with the position of the opening, if the solution is thawed, there is a risk that a part of the thawed solution will drip from the opening. In this embodiment, as described above, leakage of the second solution 8 from the opening 7a is suppressed.

[0066] The volume of the temporary containing space S3 is equal to or larger than the volume of the second solution 8. This reliably prevents the second solution 8 from leaking out from the opening 7a.

[0067] The second container 7 is a pipette tip, which makes it easy to obtain the second container 7.

[0068] Next, a manufacturing method of the measurement unit 1 will be described. As shown in Fig. 7, first, in step S11, the first container 4 is prepared. Step S11 corresponds to a first preparation step. In step S11, the first container 4 is prepared with the rotor 5 accommodated in the first accommodation space S1.

[0069] Next, in step S12, a first solution 6 is prepared. Step S12 corresponds to a solution preparation step. In step S12, multiple reagents (such as physiological saline, buffer solution, and fluorescent indicator) are mixed outside the first storage space S1. The volume of the first solution 6 prepared in step S12 is several times or more the volume of the first storage space S1. In other words, in step S12, a large amount of the first solution 6 is prepared compared to the volume of the first storage space S1. Next, in step S13, the first solution 6 prepared in advance is introduced into the first storage space S1. In step S13, the first solution 6 is introduced sequentially into the first storage spaces S1 of the multiple first containers 4.

[0070] Subsequently, in step S14, the first solution 6 is frozen in a state in which it is accommodated in the first accommodation space S1. Step S14 corresponds to a first freezing step. In step S14, the first solution 6 is frozen in a state in which the rotor 5 accommodated in the first accommodation space S1 is immersed in the first solution 6. In step S14, the first container 4 accommodating the rotor 5 and the first solution 6 is placed in a cooling space of a cooling facility. The temperature of the cooling space is, for example, about -20°C. The first container 4 is placed in the cooling space for, for example, about 2 hours. As a result, the first solution 6 is frozen, and the first measurement kit 2 is produced. The first measurement kit 2 may be stored in the cooling space. In step S14, the opening 4a of the first container 4 may be sealed by a sealing member such as parafilm or a rubber stopper.

[0071] Next, in step S15, a second container 7 is prepared. Step S15 corresponds to a second preparation step. Next, in step S16, a second solution 8 is prepared. In step S16, multiple reagents (stimulants, organic solvents, buffer solutions, etc.) are mixed outside the second storage space S2. The volume of the second solution 8 prepared in step S16 is several times or more the volume of the second storage space S2. In other words, in step S16, a large amount of the second solution 8 is prepared compared to the volume of the second storage space S2.

[0072] Next, in step S17, a second solution 8 prepared in advance is introduced into the second housing space S2. Step S17 corresponds to a solution introducing step. In step S17, the second solution 8 is sucked into the second housing space S2 through the opening 7a, and then air is further sucked into the second housing space S2 through the opening 7a.

[0073] Specifically, in step S17, a specified amount of the second solution 8 is placed in a spare container such as a microtube or a microplate. Then, a suction nozzle is inserted into the opening 7b of the second container 7. Then, the second container 7 is placed so that the opening 7a of the second container 7 is in contact with the second solution 8. Then, a specified amount of the second solution 8 is sucked into the second accommodation space S2 through the opening 7a by the suction force of the suction nozzle. Then, air is sucked into the second accommodation space S2 through the opening 7a. As a result, a temporary accommodation space S3 is formed between the opening 7a and the second solution 8. The volume of the air sucked in step S17 is equal to or larger than the volume of the second solution 8 sucked in step S17. Note that in step S17, for example, the second solution 8 placed in one spare container may be introduced into the second accommodation spaces S2 of multiple second containers 7 at the same time.

[0074] Next, in step S18, the second solution 8 is frozen in the state of being accommodated in the second accommodation space S2. Step S18 corresponds to a second freezing step. In step S18, the suction nozzle is removed from the opening 7b of the second container 7. Next, in a state in which a temporary accommodation space S3 exists between the opening 7a and the second solution 8 and a space S4 exists between the opening 7b and the second solution 8, the second container 7 is placed in a cooling space of the cooling equipment. The temperature of the cooling space is, for example, about -80°C. The second container 7 is placed in the cooling space for, for example, about one hour. As a result, the second solution 8 is frozen and the second measurement kit 3 is produced. The second measurement kit 3 may be stored in the cooling space. One first measurement kit 2 and one second measurement kit 3 may be stored in the same cooling space in a state of being accommodated in one package. At least one of steps S15 to S18 may be performed simultaneously with at least one of steps S11 to S14.

[0075] As described above, according to this manufacturing method, it is possible to manufacture the measurement unit 1 that exhibits the above-mentioned effects.

[0076] In step S12, the multiple reagents are mixed outside the first storage space S1. This allows the first solution 6 prepared outside the first storage space S1 to be introduced sequentially into the first storage spaces S1 of the multiple first containers 4, thereby improving the manufacturing efficiency of the measurement unit 1.

[0077] In step S14, the first solution 6 is frozen in a state in which the rotor 5 accommodated in the first accommodation space S1 is immersed in the first solution 6. In this way, the measurement unit 1 having the rotor 5 immersed in the first solution 6 can be manufactured.

[0078] In step S18, the second solution 8 is frozen in a state in which a temporary accommodation space S3 exists between the second solution 8 and the opening 7a. As a result, even if a part of the second solution 8 moves toward the opening 7a in step S18, the part of the second solution 8 is accommodated in the temporary accommodation space S3, and therefore leakage of the second solution 8 from the opening 7a is suppressed.

[0079] In step S17, the second solution 8 is sucked into the second housing space S2 through the opening 7a, and then air is further sucked into the second housing space S2 through the opening 7a. This allows a temporary housing space S3 to be formed between the second solution 8 and the opening 7a. Also, a specified amount of the second solution 8 can be accurately sucked into the second housing space S2.

[0080] The volume of the air sucked in step S17 is equal to or greater than the volume of the second solution 8 sucked in step S17. This reliably prevents the second solution 8 from leaking out of the opening 7a.

[0081] Next, a biological sample measurement method using the measurement unit 1 will be described. First, the measurement device will be described. As shown in FIG. 8 and FIG. 9, the measurement device 9 includes a support member 91, a heater 92, a nozzle 93, a rotation device 94, and a light device 95. The support member 91 includes a mounting space (slot) 91a and an opening 91b. The opening 91b penetrates the side wall of the support member 91. The opening 91b communicates with the mounting space 91a. The first measurement kit 2 is mounted in the mounting space 91a so that the light transmission region 4b faces the opening 91b. The heater 92 is provided on the side wall of the support member 91. When viewed from the Y-axis direction, the heater 92 is provided on both sides in the X-axis direction with respect to the mounting space 91a. Heat generated by the heater 92 moves to the first measurement kit 2 through the support member 91.

[0082] The nozzle 93 is disposed vertically above the support member 91. The nozzle 93 ejects, for example, air. The opening 7b of the second container 7 is attached to the nozzle 93. When air is ejected from the nozzle 93, the pressure in the space S4 becomes greater than the pressure in the temporary accommodation space S3. The thawed second solution 8 is discharged from the opening 7a due to the pressure difference between the space S4 and the temporary accommodation space S3. The second solution 8 discharged from the opening 7a is added to the first accommodation space S1 of the first container 4.

[0083] The rotation device 94 is disposed on the opposite side of the mounting space 91a from the opening 91b. The rotation device 94 is, for example, a magnetic stirrer. The rotation device 94 rotates the rotor 5 of the first measurement kit 2.

[0084] The light device 95 is disposed on the opposite side of the rotating device 94 with respect to the mounting space 91a. The light device 95 has an excitation unit 96, an optical system 97, and a light receiving unit 98. The excitation unit 96 has a light emitting element such as a laser diode or a light emitting diode. The excitation unit 96 emits excitation light. The optical system 97 is disposed between the excitation unit 96 and the mounting space 91a, and between the light receiving unit 98 and the mounting space 91a. The optical system 97 is, for example, a lens that collects light. The light receiving unit 98 has a photoelectric conversion element such as a photodiode. The light receiving unit 98 detects the incident light. The excitation light emitted from the excitation unit 96 reaches the first storage space S1 through the optical system 97, the opening 91b, and the light transmitting region 4b. As a result, a substance generated by the reaction between a component generated from the biological sample and the fluorescent indicator in the first solution 6 is excited, and as a result, fluorescence is generated. The fluorescence reaches the light receiving unit 98 via the light transmitting region 4b, the opening 91b, and the optical system 97. The light receiving unit 98 detects the fluorescence.

[0085] 10, in the biological sample measurement method, first, in step S21, the measurement unit 1 is prepared. Step S21 corresponds to the preparation step.

[0086] Subsequently, in step S22, the first solution 6 is thawed. Step S22 corresponds to a first thawing step. In step S22, the first measurement kit 2 is mounted in the mounting space 91a. In step S22, the first solution 6 is heated by the heater 92 until it is thawed. The heat of the heater 92 is transferred to the first solution 6 via the support member 91 and the first container 4. In step S22, the first solution 6 continues to be heated so that the temperature of the first solution 6 reaches an appropriate temperature (optimum temperature) for the biological sample. The optimal temperature for the biological sample is, for example, 37°C. In step S22, the first solution 6 is heated so that the temperature of the first solution 6 reaches, for example, 36.5°C to 37.5°C. In step S22, the first solution 6 is heated for, for example, 5 to 10 minutes. As a result, the first solution 6 is heated relatively slowly, and thus functional deterioration of the first solution 6 is suppressed.

[0087] In step S22, the first solution 6 is heated while the rotor 5 is rotated. Specifically, in step S22, the rotor 5 is rotated after the first solution 6 is thawed and becomes flowable. When the rotor 5 rotates, the first solution 6 flows sequentially through the first region 42c, one side of the intermediate region 42e, the second region 42d, and the other side of the intermediate region 42e, and flows from the other side of the intermediate region 42e to the one side of the intermediate region 42e through the region between the partition wall 422 and the inner surface of the first member 41. This promotes heat transfer in the first solution 6, and improves the thawing efficiency of the first solution 6. In step S22, the rotation device 94 may be started before the first solution 6 becomes flowable (for example, before the first measurement kit 2 is mounted in the mounting space 91a). In this case, the rotor 5 rotates at the same time as the first solution 6 becomes flowable.

[0088] Next, in step S23, the biological sample is added to the first storage space S1 through the opening 4a. Step S23 corresponds to a first adding step. In step S23, a small amount (about 2 μL to 3 μL) of peripheral blood collected from the subject's finger using a blood collection device such as a lancet is added to the first storage space S1 as the biological sample.

[0089] Next, in step S24, the temperature of the first solution 6 is adjusted. Step S24 corresponds to a temperature adjustment step. In step S24, the first solution 6 is heated by heater 92. In step S24, the first solution 6 is heated so that the temperature of the first solution 6 is maintained at the above-mentioned optimum temperature for the biological sample. In step S24, the first solution 6 is heated so that the temperature of the first solution 6 becomes, for example, 36.8°C to 37.2°C. In step S24, the first solution 6 is heated while rotating the rotor 5. Step S24 is continued until the biological sample measurement method is completed.

[0090] Subsequently, in step S25, the second solution 8 is thawed. Step S25 corresponds to a second thawing step. In step S25, the second measurement kit 3 is left for 1 to 2 minutes with the second container 7 of the second measurement kit 3 attached to the nozzle 93. That is, in step S25, the second solution 8 is naturally thawed. Since the temporary storage space S3 exists between the second solution 8 and the opening 7a, even if a part of the thawed second solution 8 moves toward the opening 7a, the part of the second solution 8 is stored in the temporary storage space S3. While the second solution 8 is thawed, the air present in the space S4 expands due to a rise in the temperature of the air present in the space S4. When the air present in the space S4 expands, the thawed second solution 8 moves toward the opening 7a and the volume of the temporary storage space S3 decreases. However, the temporary storage space S3 still exists between the second solution 8 after the movement and the opening 7a. In a state where the thawing of the second solution 8 is completed, the thawed second solution 8 may reach the opening 7a. That is, when the thawing of the second solution 8 is completed, there may be no space between the second solution 8 and the opening 7a. Step S25 may be performed simultaneously with at least one of steps S22 to S24.

[0091] Next, in step S26, the second solution 8 after thawing is discharged from the opening 7a and added to the first storage space S1 through the opening 4a. Step S26 corresponds to the second adding step. In step S26, the contents from a predetermined position on the opposite side of the opening 7a with respect to the second solution 8 in the second storage space S2 to the opening 7a are discharged from the opening 7a. The predetermined position is a position between the surface 8b of the second solution 8 and the opening 7b. In other words, the predetermined position is away from the surface 8b of the second solution 8. In step S26, the contents having a volume larger than the sum of the volume of the second solution 8 after thawing and the volume of the temporary storage space S3 are discharged from the opening 7a. In step S26, air is discharged from the nozzle 93. The volume of the discharged air is larger than the sum of the volume of the second solution 8 after thawing and the volume of the temporary storage space S3. This ensures that the second solution 8 and the contents located on the opening 7a side of the second solution 8 are discharged from the opening 7a. In step S26, the second solution 8 may be added to the first storage space S1 while the temperature of the second solution 8 is maintained at an appropriate temperature (optimum temperature) for the stimulant.

[0092] Next, in step S27, the light generated in the first storage space S1 and transmitted through the light transmission region 4b of the first container 4 is measured. Step S27 corresponds to a measurement step. In step S27, the excitation light continues to be irradiated onto the first storage space S1, and the light generated in the first storage space S1 continues to be detected. The irradiation of the excitation light and the detection of the light begin before step S26. In other words, the irradiation of the excitation light and the detection of the light begin before the second solution 8 is added to the first container 4.

[0093] When excitation light with a wavelength of about 480 nm is irradiated onto the first storage space S1 in which the reaction between the fluorescent indicator in the first solution 6 and HOCl generated from the biological sample is progressing, fluorescence with a wavelength of about 515 nm is generated in the first storage space S1. In step S27, the fluorescence with a wavelength of about 515 nm is detected. This allows the myeloperoxidase activity to be measured.

[0094] As described above, in the biological sample measurement method of this embodiment, the first solution 6, which is a mixture of multiple reagents, is prepared in a state where it is contained in the first storage space S1 of the first container 4 and frozen. This allows the measurement unit 1 to be carried near the subject with the first solution 6 frozen, and after the first solution 6 is thawed near the subject, a biological sample collected from the subject can be added to the first solution 6. Therefore, not only is the quality of the first solution 6 maintained, but also, in the vicinity of the subject, work such as preparation of the first solution 6 and introduction of the first solution 6 into the first container 4 is not required. In addition, in the biological sample measurement method of this embodiment, the second solution 8 is prepared in a state where it is contained in the second storage space S2 of the second container 7 and frozen. This allows the measurement unit 1 to be carried near the subject with the second solution 8 frozen, and after the second solution 8 is thawed near the subject, the thawed second solution 8 can be added to the first solution 6. Therefore, not only is the quality of the second solution 8 maintained, but also tasks such as preparing the second solution 8 and introducing the second solution 8 into the second container 7 are not required near the subject. As described above, according to the biological sample measurement method of the present embodiment, the quality of the first solution 6 and the second solution 8 is maintained and the task of measuring the characteristics of the biological sample is simplified.

[0095] In step S22, the first solution 6 continues to be heated so that the temperature of the first solution 6 reaches an appropriate temperature for the biological sample, and in step S24, the first solution 6 is heated so that the temperature of the first solution 6 is maintained at an appropriate temperature for the biological sample. This allows the first solution 6 to be thawed, and also maintains an appropriate temperature environment for the biological sample.

[0096] In step S21, the rotator 5 immersed in the first solution 6 is prepared, and in step S24, the first solution 6 is heated while the rotator 5 is rotated. This promotes temperature adjustment of the first solution 6 and dispersion of the biological sample into the first solution 6. In addition, in step S22, the first solution 6 is thawed while the rotator 5 is rotated, so that the thawing efficiency of the first solution 6 is improved.

[0097] In step S26, the contents in the second storage space S2 from a predetermined position on the opposite side of the opening 7a with respect to the second solution 8 to the opening 7a are discharged from the opening 7a. This ensures that all of the second solution 8 contained in the second storage space S2 is discharged from the opening 7a.

[0098] Although one embodiment of the present invention has been described above, the present invention is not limited to the above-described embodiment.

[0099] 11 and 12, the measurement unit 1 may include a first measurement kit 2A instead of the first measurement kit 2. The first measurement kit 2A differs from the first measurement kit 2 mainly in that it includes a first container 4A instead of the first container 4.

[0100] The first container 4A has a first plate member 43 and a second plate member 44. The first plate member 43 has, for example, a rectangular plate shape. The first plate member 43 includes main surfaces 43a and 43b, a recessed portion 431, a partition wall 432, and a support portion 433. The main surfaces 43a and 43b face opposite each other in the Y-axis direction (thickness direction of the first container 4A). The recessed portion 431 is formed on the main surface 43a. When viewed from the Y-axis direction, the recessed portion 431 extends along the Z-axis direction (height direction of the first container 4A). The recessed portion 431 reaches one end of the first plate member 43 in the Z-axis direction, and does not reach the other end of the first plate member 43 in the Z-axis direction.

[0101] The partition wall 432 protrudes from the bottom surface of the recess 431. The height (width in the Y-axis direction) of the partition wall 432 is smaller than the depth of the recess 431. The top surface of the partition wall 432 is located between the main surfaces 43a and 43b. When viewed from the Y-axis direction, the partition wall 432 extends along the Z-axis direction. Both ends of the partition wall 432 in the Z-axis direction are located more inward than both ends of the recess 431 in the Z-axis direction. The partition wall 432 is a partial region of the first plate member 43.

[0102] The recess 431 includes a first region 43c, a second region 43d, and an intermediate region 43e. The first region 43c is located on one side of the partition wall 432 in the Z-axis direction. The first region 43c has, for example, a rectangular shape when viewed from the Y-axis direction. The first region 43c opens at one end of the first plate member 43 in the Z-axis direction. The second region 43d is located on the other side of the partition wall 432 in the Z-axis direction. When viewed from the Y-axis direction, the width of the second region 43d in the X-axis direction (width direction of the first container 4A) gradually decreases from one end side of the first plate member 43 in the Z-axis direction to the other end side of the first plate member 43 in the Z-axis direction. That is, the recess 431 includes an inner surface 43f having a curved surface shape. When viewed from the Y-axis direction, the inner surface 43f is curved toward the opposite side of the partition wall 432.

[0103] The intermediate region 43e is located between the first region 43c and the second region 43d. The intermediate region 43e is connected to each of the first region 43c and the second region 43d. When viewed from the Y-axis direction, the intermediate region 43e has, for example, a rectangular shape. When viewed from the Y-axis direction, the position of one end of the intermediate region 43e in the Z-axis direction coincides with the position of one end of the partition wall 432 in the Z-axis direction, and the position of the other end of the intermediate region 43e in the Z-axis direction coincides with the position of the other end of the partition wall 432 in the Z-axis direction.

[0104] The support portion 433 is located in the second region 43d. The support portion 433 protrudes from the bottom surface of the recess 431. The surface of the support portion 433 is, for example, curved. The support portion 433 is a partial region of the first plate member 43.

[0105] The second plate member 44 has, for example, a rectangular plate shape. The second plate member 44 includes main surfaces 44a, 44b and a recessed portion 441. The main surfaces 44a and 44b face opposite each other in the Y-axis direction. The recessed portion 441 is formed on the main surface 44a. The recessed portion 441 opens at one end of the second plate member 44 in the Z-axis direction. The depth of the recessed portion 441 gradually increases from the other end side of the second plate member 44 in the Z-axis direction toward the one end side of the second plate member 44 in the Z-axis direction, and then is maintained at a constant value.

[0106] The main surface 44a of the second plate member 44 faces the main surface 43a of the first plate member 43. When viewed from the Y-axis direction, the outer edge of the second plate member 44 coincides with the outer edge of the first plate member 43. The recess 441 of the second plate member 44 faces the first region 43c of the first plate member 43. The second plate member 44 is fixed to the first plate member 43. The second plate member 44 is, for example, bonded to the first plate member 43. The second plate member 44 is fixed to the first plate member 43 to form a first storage space S1 of the first container 4A.

[0107] The first storage space S1 is a space formed by the recess 431 and the recess 441, excluding the partition wall 432 and the support portion 433. The width of the recess 441 in the Z-axis direction is the same as the width of the first region 43c in the Z-axis direction. The width of the recess 441 in the X-axis direction is the same as the width of the first region 43c in the X-axis direction. The opening 4a of the first container 4A is formed by the opening of the recess 441 and the opening of the first region 43c.

[0108] The second plate member 44 includes a light-transmitting region 4b. When viewed from the Y-axis direction, the light-transmitting region 4b is a region of the second plate member 44 that overlaps with the first storage space S1. Light generated in the first storage space S1 passes through the light-transmitting region 4b. In this embodiment, the entire second plate member 44 has light transmittance. The material of the second plate member 44 is, for example, a transparent resin. In this embodiment, the first plate member 43 also has light transmittance. Light generated in the first storage space S1 passes through the first plate member 43. The material of the first plate member 43 is, for example, a transparent resin. Note that the first plate member 43 does not have to have light transmittance.

[0109] In the embodiment, a human body is exemplified as a subject, but the subject may be, for example, an animal. Although an example in which the biological sample is the subject's blood has been shown, the biological sample may be, for example, a body fluid of the subject. The biological sample may be, for example, saliva, perfusate, tears, sweat, or urine of the subject. Although an example of the activity of neutrophil cells has been shown as a characteristic of the biological sample, the characteristic of the biological sample may be, for example, the activity of tissue cells such as monocytes, eosinophils, basophils, B cells, T cells, NK cells, or vascular endothelial cells.

[0110] In the embodiment, the first solution 6 contains a fluorescent indicator, but the first solution 6 may contain a chemiluminescent indicator. The chemiluminescent indicator reacts with a component (superoxide) generated from the biological sample. The chemiluminescent indicator is, for example, MCLA (2-Methyl-6-(4-methoxyphenyl)-3,7-dihydroimidazo[1,2-a]pyrazin-3-one). A commercially available product may be used as the chemiluminescent indicator. In the first storage space S1 where the reaction between the superoxide generated from the biological sample and the chemiluminescent indicator of the first solution 6 progresses, chemiluminescence with a maximum emission wavelength of about 465 nm is generated. In step S27, chemiluminescence with a maximum emission wavelength of about 465 nm may be detected. This allows the superoxide production activity to be measured.

[0111] In the embodiment, an example in which the second container 7 is a pipette tip has been shown, but the second container 7 may be, for example, a capillary nozzle, a dropper, a volumetric pipette, a Komagome pipette, a measuring pipette, a hematocrit capillary tube, or a syringe.

[0112] In the embodiment, an example has been shown in which the volume of the temporary containing space S3 is equal to or larger than the volume of the second solution 8. However, the volume of the temporary containing space S3 may be smaller than the volume of the second solution 8.

[0113] In the embodiment, an example has been shown in which the second solution 8 is introduced into the second accommodation space S2 by the suction nozzle inserted into the opening 7b of the second container 7, but the second solution 8 may be introduced into the second accommodation space S2 by the suction force of the second container 7 itself. Specifically, first, the opening 7b of the second container 7 is closed. Next, the second container 7 is pressurized from the outside of the second container 7 by, for example, an operator's hand. As a result, the air in the second accommodation space S2 is discharged through the opening 7a. Next, the second container 7 is placed so that the opening 7a of the second container 7 comes into contact with the second solution 8. Next, the pressure applied by the operator's hand is released. As a result, the second solution 8 is sucked into the second accommodation space S2 through the opening 7a.

[0114] In the embodiment, an example is shown in which the first solution 6 is heated by the heater 92 of the measuring device 9 in step S22, but in step S22, the first solution 6 may also be heated by a heating device (e.g., a pre-incubator) provided separately from the measuring device 9.

[0115] The biological sample measurement method does not have to include step S24. In this case, in step S23, the first solution 6 is heated so that the temperature of the first solution 6 becomes, for example, 36.8°C to 37.2°C.

[0116] The first solution 6 may contain, as an indicator that reacts with hypochlorous acid (or its halogen equivalent) produced by myeloperoxidase, for example, taurine / TNB (see J. Clin. Invest., Vol. 70, pp. 598-607, 1982), 8-amino-5-chloro-7-phenylpyrido[3,4-d]pyridazine-1,4-(2H,3H)dione (see L-012: Anal Biochem., Vol. 271(1), pp. 53-58, 1999), or the like.

[0117] The first solution 6 may contain an indicator that reacts with superoxide, such as 2-methyl-6-phenyl-3,7-dihydroimidazo[1,2-a]pyrazin-3-one (CLA), 2-methyl-6-p-methoxyphenylethynylimidazopyrazinone (MPEC), indocyanine-type imidazopyranodine compound (NIR-CLA), 2-[2,4,5,7-tetrafluoro-6-(2-nitro-4,5-dimethoxyphenylsulfonyloxy)-3-oxo-3H-xanthen-9-yl]benzoic acid (BES-So), or the like.

[0118] The second solution 8 may contain, for example, opsonized zymon (OZ) as a stimulant.

[0119] In the embodiment, an example has been shown in which the first solution 6 prepared in advance outside the first storage space S1 is introduced into the first storage space S1, but the first solution 6 may be prepared inside the first storage space S1. For example, each of the multiple reagents may be introduced into the first storage space S1 in a state separated from each other. Each of the multiple reagents may be introduced into the first storage space S1 sequentially or simultaneously.

[0120] In the embodiment, the example in which the second solution 8 contains a buffer solution has been shown, but the second solution 8 may not contain a buffer solution. In this case, deterioration of the stimulant caused by the buffer solution is suppressed. Specifically, the stimulant diluted with the buffer solution tends to deteriorate the longer the period until the second solution 8 is frozen. When the second solution 8 does not contain a buffer solution, even if the period until the second solution 8 is frozen is relatively long, deterioration of the stimulant is suppressed. When the second solution 8 does not contain a buffer solution, the temperature of the second solution 8 may be equal to or lower than the freezing point of the organic solvent contained in the second solution 8. The buffer solution used for preparing the second solution 8 may be prepared in step S12 in which the first solution 6 is prepared. Specifically, in step S12, a buffer solution equivalent to the total value of the amount of the buffer solution necessary for preparing the first solution 6 and the amount of the buffer solution necessary for preparing the second solution 8 may be prepared, and the first solution 6 containing the buffer solution necessary for preparing the second solution 8 may be prepared. Then, in step S13, the first solution 6 including the buffer solution necessary for preparing the second solution 8 may be introduced into the first storage space S1 of the first container 4. In other words, the buffer solution used in preparing the second solution 8 may be introduced into the first storage space S1 in step S13. Also, the buffer solution used in preparing the second solution 8 may be added to the first storage space S1 before the second solution 8 is added to the first storage space S1 in step S26.

[0121] The measuring device 9 (see FIG. 9) may have an adjustment mechanism for adjusting the position of the nozzle 93 in the Z-axis direction (vertical direction). In step S26, the second solution 8 may be added to the first solution 6 in a state in which the opening 7a (tip of the second container 7) of the second container 7 is positioned between the opening 4a of the first container 4 and the surface (liquid level) 6a of the first solution 6. The distance between the tip of the second container 7 and the surface 6a of the first solution 6 may be, for example, about 1 mm. In this case, scattering of the second solution 8 or disturbance of the surface 6a of the first solution 6 is suppressed, and as a result, a decrease in the measurement accuracy of the characteristics of the biological sample is suppressed. Specifically, when the second solution 8 does not contain a buffer solution, the amount of the second solution 8 added tends to be very small, making it difficult to control the dropping of the second solution 8 using the nozzle 93 and the second container 7. Therefore, the discharge pressure of the air from the nozzle 93 increases, and as a result, the second solution 8 may be sprayed from the opening 7a of the second container 7. When the second solution 8 is ejected from the opening 7a, the second solution 8 may scatter, which may result in a shortage of the stimulant added to the first solution 6. In addition, when the second solution 8 is ejected from the opening 7a, the surface 6a of the first solution 6 may be disturbed due to air bubbles, which may result in scattered light. The present inventors have succeeded in suppressing a decrease in the measurement accuracy of the characteristics of the biological sample caused by the scattering of the second solution 8 or the disturbance of the surface 6a of the first solution 6 by optimizing the distance between the tip of the second container 7 and the surface 6a of the first solution 6. The distance between the tip of the second container 7 and the surface 6a of the first solution 6 may be adjusted based on the amount of the second solution 8 added or the discharge pressure of the air from the nozzle 93, etc.

[0122] In step S17 (see FIG. 7) of the method for manufacturing the measurement unit 1, a pipette or the like may be used as the suction nozzle. Specifically, first, the tip of the pipette is inserted into the opening 7b of the second container 7. Then, a specified amount (e.g., 0.75 μL) of the second solution 8 is aspirated into the second storage space S2 of the second container 7 through the opening 7a of the second container 7 by the suction force of the pipette. Then, with the tip of the pipette inserted into the opening 7b of the second container 7, the suction amount of the pipette is increased to, for example, 3 μL. As a result, a predetermined amount of air is further aspirated into the second storage space S2 through the opening 7a. [Explanation of symbols]

[0123] 1...measurement unit, 2, 2A...first measurement kit, 4, 4A...first container, 3...second measurement kit, 4a...opening (first opening), 4b...light-transmitting area, 5...rotator, 6...first solution, 7...second container, 7a...opening (second opening), 8...second solution, 42f, 43f...inner surface, S1...first storage space, S2...second storage space, S3...temporary storage space.

Claims

1. A measurement unit for use in measuring a characteristic of a biological sample, comprising: a first container including a first storage space, a first opening communicating with the first storage space, and a light transmitting area transmitting light generated in the first storage space; a first solution that is a mixture of a plurality of reagents including an indicator that reacts with a component generated from the biological sample; The first solution is contained in the first containing space in a frozen state.

2. The measuring unit according to claim 1 , wherein the biological sample contains white blood cells.

3. The measuring unit according to claim 1 , wherein the indicator is a fluorescent indicator.

4. The measuring unit according to claim 1 , further comprising a rotor housed in the first housing space so as to be immersed in the first solution.

5. The measuring unit according to claim 1 , wherein the first container has a flat plate shape.

6. The measuring unit according to claim 1 , wherein the first container includes an inner surface that is curved.

7. A second container including a second storage space and a second opening communicating with the second storage space; A second solution containing a stimulant that activates the function of the biological sample, The measurement unit according to claim 1 , wherein the second solution is contained in the second containing space in a frozen state.

8. The measurement unit according to claim 7 , wherein a temporary storage space exists between the second solution and the second opening.

9. The measurement unit according to claim 8 , wherein the volume of the temporary containing space is equal to or larger than the volume of the second solution.

10. The measurement unit according to claim 7 , wherein the second container is a pipette tip.

11. 1. A method for producing a measurement unit for use in measuring a characteristic of a biological sample, comprising the steps of: a first preparation step of preparing a first container including a first storage space, a first opening communicating with the first storage space, and a light transmission area that transmits light generated in the first storage space; A method for manufacturing a measurement unit, comprising: a first freezing process in which a first solution, which is a mixture of multiple reagents including an indicator that reacts with components generated from the biological sample, is frozen while contained in the first storage space.

12. The method further includes a solution preparation step in which the first solution is prepared, The method for manufacturing a measurement unit according to claim 11 , wherein in the solution preparation step, the plurality of reagents are mixed outside the first containing space.

13. The method for manufacturing a measurement unit according to claim 11 , wherein in the first freezing step, the first solution is frozen in a state in which a rotor accommodated in the first accommodation space is immersed in the first solution.

14. a second preparation step in which a second container including a second storage space and a second opening communicating with the second storage space is prepared; The method for manufacturing a measurement unit as described in claim 11, further comprising a second freezing process in which a second solution containing a stimulant that activates a function of the biological sample is frozen while contained in the second storage space.

15. The method for manufacturing a measurement unit according to claim 14 , wherein in the second freezing step, the second solution is frozen in a state in which a temporary containing space exists between the second solution and the second opening.

16. The method further includes a solution introducing step of introducing the second solution into the second accommodation space before the second freezing step, The method for manufacturing a measurement unit according to claim 15 , wherein in the solution introduction step, after the second solution is aspirated into the second storage space through the second opening, air is further aspirated into the second storage space through the second opening.

17. The method for manufacturing a measurement unit according to claim 16 , wherein a volume of the air sucked in the solution introducing step is equal to or greater than a volume of the second solution sucked in the solution introducing step.

18. 1. A method for measuring a characteristic of a biological sample, comprising: A preparation step in which the measurement unit according to claim 7 is prepared; a first thawing step in which the first solution is thawed; a first adding step in which the biological sample is added to the first storage space through the first opening after the first thawing step; a second thawing step in which the second solution is thawed; a second adding step in which, after the second thawing step, the second solution is drawn out from the second opening and added to the first storage space through the first opening; a measuring step of measuring light that is generated in the first storage space and that has passed through the light transmitting region of the first container.

19. The method further includes a temperature adjustment step of adjusting a temperature of the first solution after the first addition step, In the first thawing step, the first solution is continuously heated so that the temperature of the first solution reaches an appropriate temperature for the biological sample; The biological sample measurement method according to claim 18 , wherein in the temperature adjustment step, the first solution is heated so that the temperature of the first solution is maintained at an appropriate temperature for the biological sample.

20. In the preparation step, a rotor immersed in the first solution is prepared; The biological sample measurement method according to claim 19 , wherein in the temperature adjustment step, the first solution is heated while the rotor is rotated.

Citation Information

Patent Citations

  • Method for evaluating activity of neutrophil cell

    JP2019213464A